Single cell morphology distinguishes genotype and drug effect in Hereditary Spastic Paraplegia
Abstract A central need for neurodegenerative diseases is to find curative drugs for the many clinical subtypes, the causative gene for most cases being unknown. This requires the classification of disease cases at the genetic and cellular level, an understanding of disease aetiology in the subtypes...
Guardado en:
Autores principales: | Gautam Wali, Shlomo Berkovsky, Daniel R. Whiten, Alan Mackay-Sim, Carolyn M. Sue |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8ca07526bb474194b884a6feb2839f05 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
ER Morphology in the Pathogenesis of Hereditary Spastic Paraplegia
por: Sonia Sonda, et al.
Publicado: (2021) -
Hereditary spastic paraplegia initially diagnosed as cerebral palsy
por: Oksana Suchowersky, et al.
Publicado: (2021) -
Bi-allelic variants in RNF170 are associated with hereditary spastic paraplegia
por: Matias Wagner, et al.
Publicado: (2019) -
Two novel truncating variants in UBAP1 are responsible for hereditary spastic paraplegia.
por: Xinchao Bian, et al.
Publicado: (2021) -
Late-Onset Leukodystrophy Mimicking Hereditary Spastic Paraplegia without Diffuse Leukodystrophy on Neuroimaging
por: Zhang T, et al.
Publicado: (2021)